News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Study: Transparency Lacking in Biomedical Literature
Anna Azvolinsky | Jan 4, 2016
Few authors make their full data available and most published papers do not clearly state funding sources and conflicts of interest.
Clinical Trial Data Underreported: Study
Kerry Grens | Nov 16, 2015
One-third of the human experiments for approved drugs failed transparency requirements.
Using FOIA to Read Scientists’ Emails
Kerry Grens | Sep 8, 2015
Journalists and activists use the Freedom of Information Act to expose academics’ relationships with industry.
More Transparency in IRB-Industry Ties
Kerry Grens | Jul 13, 2015
Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.
Device Trials Go Unpublished
Kerry Grens | Jun 24, 2015
Just half of the clinical studies used to gain premarket approval for cardiac devices ever make it into the scientific literature.
EPA Reform Bills Considered
Kerry Grens | Mar 5, 2015
If passed, Republican-led efforts to change the US Environmental Protection Agency’s handling of science may never make it past the President’s desk.
IOM Urges Data Sharing
Kerry Grens | Jan 15, 2015
The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.
Push For Data Disclosure
Kerry Grens | Nov 21, 2014
Two federal health agencies released proposed rules that would tighten the requirements for reporting clinical trial results.
EMA Gearing Up for Transparency
Kerry Grens | Jun 16, 2014
The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.
More Openness on Lab Animals
Kerry Grens | May 15, 2014
Dozens of U.K. research groups agree to publicly disclose more information about their animal subjects.